BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mirabelli E, Elkabes S. Neuropathic Pain in Multiple Sclerosis and Its Animal Models: Focus on Mechanisms, Knowledge Gaps and Future Directions. Front Neurol 2021;12:793745. [PMID: 34975739 DOI: 10.3389/fneur.2021.793745] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Murphy HM, Fetter CM, Snow NJ, Chaves AR, Downer MB, Ploughman M. Lower corticospinal excitability and greater fatigue among people with multiple sclerosis experiencing pain. Mult Scler J Exp Transl Clin 2023;9:20552173221143398. [PMID: 36636581 DOI: 10.1177/20552173221143398] [Reference Citation Analysis]
2 Antunes FTT, De Souza AH, Figueira J, Binda NS, Carvalho VPR, Vieira LB, Gomez MV. Targeting N-type calcium channels in young-onset of some neurological diseases. Front Cell Dev Biol 2022;10:1090765. [PMID: 36601540 DOI: 10.3389/fcell.2022.1090765] [Reference Citation Analysis]
3 Faraji J, Gustafson C, Bettenson D, Negoro H, Yong VW, Metz GAS. Bladder dysfunction in experimental autoimmune encephalomyelitis reflects clinical severity: A pilot study. J Neuroimmunol 2022;372:577973. [PMID: 36209613 DOI: 10.1016/j.jneuroim.2022.577973] [Reference Citation Analysis]
4 Temmermand R, Barrett JE, Fontana ACK. Glutamatergic systems in neuropathic pain and emerging non-opioid therapies. Pharmacol Res 2022;185:106492. [PMID: 36228868 DOI: 10.1016/j.phrs.2022.106492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kwilasz AJ, Clements MA, Larson TA, Harris KM, Litwiler ST, Woodall BJ, Todd LS, Schrama AEW, Mitten EH, Maier SF, Van Dam A, Rice KC, Watkins LR. Involvement of TLR2–TLR4, NLRP3, and IL-17 in pain induced by a novel Sprague-Dawley rat model of experimental autoimmune encephalomyelitis. Front Pain Res 2022;3. [DOI: 10.3389/fpain.2022.932530] [Reference Citation Analysis]
6 Acioglu C, Heary RF, Elkabes S. Roles of neuronal toll-like receptors in neuropathic pain and central nervous system injuries and diseases. Brain Behav Immun 2022;102:163-78. [PMID: 35176442 DOI: 10.1016/j.bbi.2022.02.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
7 Longoria V, Parcel H, Toma B, Minhas A, Zeine R. Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination. Biomedicines 2022;10:539. [DOI: 10.3390/biomedicines10030539] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]